眼睑癌放射治疗100例分析

RADIOTHERAPY OF CARCINOMA OF EYELID - Report on 100 patients

我院从1966年至1984年共收治100例眼睑癌。单纯放疗82例,术后放疗17例,术前后放疗1例。照射采用120～180KV-X线,SSD30～40cm,半价层0.5～0.95mm Cu。术前29例快速照射30～42.5Gy/4～5次,共5～10天。53例常规照射50～60Gy/20～30次,24～36天。术后放疗30～60Gy,5～30次,共6～48天,全组5年生存率为87％(87/100)。综合组和单纯放疗生存无差异。T_4患者较T_(1-3)生存率低,但无统计差异,死亡原因主要为局部复发和远地转移。

From 1966 to 1984, 100 patients with carcinoma of the eyelid were treated, 17 with combined surgery and postoperative radiotherapy, 1 with preoperative radiotherapy and surgery and 82 with radiotherapy along. 120-180 KV-X rays, HVL 0. 5-0. 95 mm Cu, SSD 30-40 cm were used. Accelerated fractionation (30-42. 5 Gy/4-5 F/5-10 d), conventional fractionation (50-60 Gy/20-30 F/24-36 d) or 30-60 Gy/5-30 F/6-48 d (for postoperative radiation) was applied. The overall 5 year survival rate was 87%(87/100). The results of radiotherapy alone and those of combined therapy were similar. The T3 lesions did better than the T4 ones. Those who failed died either from local recurrence or distant metastasis.